Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;39(4):129-37.
doi: 10.4070/kcj.2009.39.4.129. Epub 2009 Apr 28.

Personalized medicine in coronary artery disease: insights from genomic research

Sang-Hak Lee  1 , Dong-Jik Shin, Yangsoo Jang
Affiliations

Personalized medicine in coronary artery disease: insights from genomic research

Sang-Hak Lee et al. Korean Circ J. 2009 Apr.

Abstract

Prior clinical studies have demonstrated that a family history of coronary artery disease (CAD) is associated with future cardiovascular events. Although there are several Mendelian disorders that are associated with CAD, most common forms of CAD are believed to be multifactorial and the result of many genes with small individual effects. The identification of these genes and their variation would be very helpful for the prediction, prevention, and management of CAD; linkage analysis or candidate gene case-control studies have been largely unsuccessful. On the contrary, recent advances in genomic techniques have generated a large amount of deoxyribonucleic acid (DNA)-based information. The link between CAD and inflammation and biological pathways has been highlighted. In particular, several genome-wide association studies have replicated a novel gene marker on chromosome 9p21. The information gained from genomic studies, in combination with clinical data, is expected to refine personalized approaches to assess risk and guide management for CAD. Genetic risk scores derived from several functional single nucleotide polymorphisms (SNPs) or haplotypes in multiple genes may improve the prediction of CAD. Despite the complexity of CAD genetics, steady progress is expected.

Keywords: Coronary artery disease; Genes; Genomics; Polymorphism, single nucleotide; Risk.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Variants with different frequencies, penetrance, and disease susceptibility. GWA: genome-wide association.
Fig. 2
Fig. 2
Biological pathways implicated in CAD pathophysiology and examples of genes. PCSK9: proprotein convertase subtilisin/kexin 9, APOA5: apoliprotein A-V, USF1: upstream transcription factor 1, CAD: coronary artery disease, FLAP: 5'-lipoxygenase activating protein, OX40L: OX40 ligand, MEF2A: monocyte enhancer factor 2a, GP: glycoprotein, LDL: low-density lipoprotein-cholesterol, HDL: high-density lipoprotein-cholesterol, TG: triglyceride, EC: endothelial cell.
Fig. 3
Fig. 3
Combining information from genomic, molecular, and clinical data for personalized medicine in coronary artery disease.
See this image and copyright information in PMC

References

    1. Lloyd-Jones D, Nam BH, D'Agostino RB, Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291:2204–2211. - PubMed
    1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952. - PubMed
    1. Miller DT, Ridker PM, Libby P, Kwiatkowski DJ. Atherosclerosis: the path from genomics to therapeutics. J Am Coll Cardiol. 2007;49:1589–1599. - PubMed
    1. Cambien F, Tiret L. Genetics of cardiovascular disease: from single mutations to the whole genome. Circulation. 2007;116:1714–1724. - PubMed
    1. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356–369. - PubMed